(Press-News.org) A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults. The technique works by replacing a malfunctioning gene in the eye with a normal working copy that supplies a protein necessary for light-sensitive cells in the eye to function. The findings are published today (Monday, Jan. 23) in the Proceedings of the National Academy of Sciences online.
Several complex and costly steps remain before the gene therapy technique can be used in humans, but once at that stage, it has great potential to change lives.
"Imagine that you can't see or can just barely see, and that could be changed to function at some levels so that you could read, navigate, maybe even drive — it would change your life considerably," said study co-author William W. Hauswirth, Ph.D., the Rybaczki-Bullard professor of ophthalmology in the UF College of Medicine and a professor and eminent scholar in department of molecular genetics and microbiology and the UF Genetics Institute. "Providing the gene that's missing is one of the ultimate ways of treating disease and restoring significant visual function."
The researchers tackled a condition called X-linked retinitis pigmentosa, a genetic defect that is passed from mothers to sons. Girls carry the trait, but do not have the kind of vision loss seen among boys. About 100,000 people in the U.S. have a form of retinitis pigmentosa, which is characterized by initial loss of peripheral vision and night vision, which eventually progresses to tunnel vision, then blindness. In some cases, loss of sight coincides with the appearance of dark-colored areas on the usually orange-colored retina.
The UF researchers previously had success pioneering the use of gene therapy in clinical trials to reverse a form of blindness known as Leber's congenital amaurosis. About 5 percent of people who have retinitis pigmentosa have this form, which affects the eye's inner lining.
"That was a great advance, which showed that gene therapy is safe and lasts for years in humans, but this new study has the potential for a bigger impact, because it is treating a form of the disease that affects many more people," said John G. Flannery, Ph.D., a professor of neurobiology at the University of California, Berkeley who is an expert in the design of viruses for delivering replacement genes. Flannery was not involved in the current study.
The X-linked form of retinitis pigmentosa addressed in the new study is the most common, and is caused by degeneration of light-sensitive cells in the eyes known as photoreceptor cells. It starts early in life, so though affected children are often born seeing, they gradually lose their vision.
"These children often go blind in the second decade of life, which is a very crucial period," said co-author Alfred S. Lewin, Ph.D., a professor in the UF College of Medicine department of molecular genetics and microbiology and a member of the UF Genetics Institute. "This is a compelling reason to try to develop a therapy, because this disease hinders people's ability to fully experience their world."
Both Lewin and Hauswirth are members of UF's Powell Gene Therapy Center.
The UF researchers and colleagues at the University of Pennsylvania performed the technically challenging task of cloning a working copy of the affected gene into a virus that served as a delivery vehicle to transport it to the appropriate part of the eye. They also cloned a genetic "switch" that would turn on the gene once it was in place, so it could start producing a protein needed for the damaged eye cells to function.
After laboratory tests proved successful, the researchers expanded their NIH-funded studies and were able to cure animals in which X-linked retinitis pigmentosa occurs naturally. The injected genes made their way only to the spot where they were needed, and not to any other places in the body. The study gave a good approximation of how the gene therapy might work in humans.
"The results are encouraging and the rescue of the damaged photoreceptor cells is quite convincing," said Flannery, who is on the scientific advisory board of the Foundation Fighting Blindness, which provided some funding for the study. "Since this type of study is often the step before applying a treatment to human patients, showing that it works is critical."
The researchers plan to repeat their studies on a larger scale over a longer term, and make a version of the virus that proves to be safe in humans. Once that is achieved, a pharmaceutical grade of the virus would have to be produced and tested before moving into clinical trials in humans. The researchers will be able to use much of the technology they have already developed and used successfully to restore vision.
### END
Researchers develop gene therapy that could correct a common form of blindness
2012-01-25
ELSE PRESS RELEASES FROM THIS DATE:
Rate of physician referrals nearly doubled
2012-01-25
BOSTON, MA -- Physician referral rates in the United States doubled between 1999 and 2009, a new study finds, an increase that likely contributes to the rising costs of health care.
The increase in referral rates coincides with an increase in chronic conditions such as Type 2 diabetes. The results are staggering: over the same time period, the estimated absolute number of visits resulting in a referral increased 159 per cent, from 40.6 million to 105 million.
"If you add that up, it's real money," said Bruce Landon, senior author of the paper and professor of health ...
Use of iodinated contrast media in imaging procedures appears to affect thyroid function
2012-01-25
CHICAGO—Exposure to iodinated contrast media during imaging procedures is associated with changes in thyroid function, and increased risk of developing hyperthyroidism, according to a report in the January 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
"Iodinated contrast media (ICM) are commonly administered pharmaceutical agents," the authors write as background information. ICM are frequently used in scans and imaging procedures such as cardiac catheterization and computed tomography (CT scans). "Although certain complications of ICM ...
Researchers quantify muscle soreness
2012-01-25
Quantifying how sore a person is after a long workout is a challenge for doctors and researchers, but scientists from Loma Linda and Asuza Pacific Universities think they may have figured it out. Their research article describing a new technique to measure muscle soreness will be published in the Journal of Visualized Experiments (JoVE).
Delayed onset muscle soreness (DOMS) or exercise-induced muscle damage (EIMD) is one of the most common sports injuries, but without a reliable method of quantifying muscle soreness, assessing treatments is difficult.
Traditionally, ...
CU School of Medicine researchers look at effects of 2 common sweeteners on the body
2012-01-25
AURORA, Colo. (Jan. 23, 2012) - With growing concern that excessive levels of fructose may pose a great health risk – causing high blood pressure, kidney disease and diabetes – researchers at the University of Colorado School of Medicine, along with their colleagues at the University of Florida, set out to see if two common sweeteners in western diets differ in their effects on the body in the first few hours after ingestion. The study, recently published in the journal Metabolism, took a closer look at high fructose corn syrup (HFCS) and table sugar (sucrose) and was ...
Neuropathy patients more likely to receive high-cost, screening instead of more effective tests
2012-01-25
Researchers at the University of Michigan analyzed the tremendous cost of diagnosing peripheral neuropathy and found that less expensive, more effective tests are less likely to be used.
Almost one-quarter of patients receiving neuropathy diagnoses undergo high-cost, low-yield MRIs while very few receive low-cost, high-yield glucose tolerance tests, according to the study that will be published Jan. 23 in the Archives of Internal Medicine.
The research was led by Brian Callaghan, M.D., assistant professor of neurology at the University of Michigan Medical School.
Patients ...
New tool enhances view of muscles
2012-01-25
Simon Fraser University associate professor James Wakeling is adding to the arsenal of increasingly sophisticated medical imaging tools with a new signal-processing method for viewing muscle activation details that have never been seen before.
Fascinated with the mechanics of muscle movement in people and animals, Wakeling has developed a novel method using ultrasound imaging, 3D motion-capture technology and proprietary data-processing software to scan and capture 3D maps of the muscle structure — in just 90 seconds.
It's a medical-imaging breakthrough because previous ...
Van Andel research institute study provides new details of fundamental cellular process
2012-01-25
Grand Rapids, Mich. – A recent Van Andel Research Institute (VARI) study published in the journal Science investigating the molecular structure and function of an essential plant hormone could profoundly change our understanding of a key cell process, and might ultimately lead to the development of new drugs for a variety of diseases.
The study builds on earlier work by the same team of investigators at VARI that was published in the journal Nature in 2009. That study shed light on how plants respond when they are under stress from extreme temperatures, drought and other ...
Metadynamics technique offers insight into mineral growth and dissolution
2012-01-25
By using a novel technique to better understand mineral growth and dissolution, researchers at the Department of Energy's Oak Ridge National Laboratory are improving predictions of mineral reactions and laying the groundwork for applications ranging from keeping oil pipes clear to sequestering radium.
The mineral barite was examined to understand mineral growth and dissolution generally, but also because it is the dominant scale-forming mineral that precipitates in oil pipelines and reservoirs in the North Sea. Oil companies use a variety of compounds to inhibit scale ...
Powerful people feel taller than they are
2012-01-25
After the huge 2010 oil spill in the Gulf of Mexico, the chairman of BP referred to the victims of the spill as the "small people." He explained it as awkward word choice by a non-native speaker of English, but the authors of a new paper published in Psychological Science, a journal of the Association for Psychological Science, wondered if there was something real behind it. In their study, they found that people who feel powerful tend to overestimate their own height—they feel physically larger than they actually are.
"Maybe there's a physical experience that goes along ...
To 'think outside the box,' think outside the box
2012-01-25
Want to think outside the box? Try actually thinking outside of a box. In a study to be published in an upcoming issue of Psychological Science, a journal of the Association for Psychological Science, researchers had students think up solutions to problems while acting out various metaphors about creative thinking and found that the instructions actually worked.
The authors of the new paper were inspired by metaphors about creativity found in boardrooms to movie studios to scientific laboratories around the world and previous linkages established between mind and body. ...